soon
first
isol
influenza
c
viru
patient
taylor
becam
obviou
viru
differ
myxovirus
sever
aspect
pronounc
differ
observ
interact
viru
cell
surfac
suggest
influenza
c
viru
attach
receptor
differ
recogn
myxovirus
influenza
b
virus
agglutin
erythrocyt
mani
speci
includ
human
spectrum
erythrocyt
agglutin
influenza
c
viru
much
restrict
erythrocyt
rat
mice
adult
chicken
suitabl
hemagglutin
hemadsorpt
test
cell
speci
howev
react
poorli
influenza
c
viru
hirst
minus
et
al
chakraverti
ohuchi
et
al
differ
also
observ
far
hemagglutin
inhibitor
concern
varieti
glycoprotein
shown
prevent
influenza
b
virus
agglutin
erythrocyt
case
influenza
c
viru
rat
serum
long
time
known
hemagglutin
inhibitor
styk
ocallaghan
et
al
differ
receptor
influenza
c
viru
myxovirus
also
suggest
studi
receptordestroy
enzym
abil
influenza
c
viru
inactiv
receptor
report
soon
first
isol
viru
patient
hirst
howev
influenza
c
enzym
affect
receptor
myxovirus
convers
receptordestroy
enzym
either
latter
virus
unabl
inactiv
receptor
influenza
c
viru
erythrocyt
enzym
influenza
b
viru
character
neuraminidas
klenk
et
al
even
refin
methodolog
activ
detect
influenza
c
viru
kendal
nerom
et
al
known
receptorbind
receptordestroy
activ
well
fusion
activ
influenza
c
viru
mediat
glycoprotein
present
surfac
viru
particl
structur
function
protein
design
hef
review
follow
section
two
strain
influenza
c
viru
rna
segment
contain
genet
inform
hef
clone
sequenc
nakada
et
al
pfeifer
compan
sequenc
data
sever
strain
obtain
direct
sequenc
viral
rna
buonagurio
et
al
adachi
et
al
gene
nucleotid
length
code
polypeptid
amino
acid
fig
predict
polypeptid
molecular
weight
amino
terminu
stretch
hydrophob
amino
acid
may
repres
signal
sequenc
cleavag
sequenc
result
polypeptid
molecular
weight
two
addit
hydrophob
sequenc
locat
posit
former
probabl
involv
fusion
activ
discuss
section
c
hydrophob
amino
acid
sequenc
carboxytermin
end
assum
function
membran
anchor
follow
cytoplasm
tail
three
amino
acid
homolog
observ
hemagglutinin
influenza
b
virus
krystal
et
al
signific
valu
homolog
found
glycoprotein
compar
hef
protein
influenza
c
viru
similar
hef
sequenc
ha
sequenc
restrict
presenc
three
hydrophob
domain
mention
use
criterion
sequenc
align
report
six
nine
cystein
conserv
glycoprotein
three
type
influenza
viru
nakada
et
al
heifer
compan
comparison
influenza
c
protein
influenza
b
counterpart
also
reveal
low
degre
sequenc
similar
yamashita
et
al
togeth
sequenc
data
suggest
influenza
b
virus
close
relat
one
anoth
influenza
c
viru
among
modif
hef
polypeptid
gycosyl
studi
greatest
detail
presenc
inhibitor
tunicamycin
unglycosyl
form
protein
obtain
nagel
hongo
et
al
find
indic
nativ
glycoprotein
contain
nlink
oligosaccharid
carbohydr
structur
absent
indic
fig
amino
acid
sequenc
contain
eight
consensu
sequenc
asnxserthr
suitabl
attach
nlink
oligosaccharid
nakada
et
al
pfeifer
compan
analysi
synthesi
influenza
c
glycoprotein
presenc
limit
concentr
glycosyl
inhibitor
suggest
presenc
seven
oligosaccharid
nativ
protein
nagel
six
hef
portion
one
hef
three
size
class
oligosaccharidesgi
g
resolv
gel
chromatographi
nakamura
et
al
oligosaccharid
correspond
two
smaller
size
class
ie
g
also
observ
influenza
viru
gi
restrict
influenza
c
viru
g
appear
repres
mannoserich
type
oligosaccharid
oligosaccharid
size
class
gi
g
shown
contain
nacetylneuramin
acid
indic
complex
type
presenc
sialic
acid
viral
surfac
influenza
c
viru
abl
inhibit
hemagglutin
activ
influenza
virus
nerom
et
al
meierewert
et
al
structur
differ
oligosaccharid
determin
suggest
hef
polypeptid
contain
predominantli
oligosaccharid
larger
size
class
other
glycosyl
smaller
size
class
nagel
would
provid
explan
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
hef
detect
doublet
band
herrler
et
al
sugawara
et
al
discuss
section
ii
glycosyl
hef
import
present
antigen
epitop
furthermor
carbohydr
side
chain
crucial
stabil
glycoprotein
protect
proteolyt
degrad
presenc
tunicamycin
virion
releas
infect
cell
howev
viru
particl
lack
surfac
protein
hongo
et
al
anoth
posttransl
modif
hef
proteolyt
cleavag
precursor
polypeptid
hef
cleavag
product
hef
hef
discuss
section
iii
c
modif
requir
viral
fusion
activ
cleavag
caus
cellular
proteas
cultur
cell
eg
chick
embryo
fibroblast
madindarbi
canin
kidney
mdck
cell
lack
appropri
enzym
low
amount
surfac
virion
releas
cell
glycoprotein
hef
found
predominantli
uncleav
form
cleav
uitro
incub
trypsin
elastas
compan
et
al
herrler
et
al
sugawara
et
al
influenza
c
virus
grown
embryon
egg
primari
chick
kidney
cell
contain
glycoprotein
molecul
cleav
form
cleavag
product
detect
sdspage
presenc
reduc
agent
herrler
et
al
observ
indic
two
polypeptid
held
togeth
disulfid
bond
observ
sever
viral
surfac
glycoprotein
proteolyt
cleav
disulfid
bond
contribut
uniqu
electrophoret
behavior
hef
observ
glycoprotein
influenza
virus
nonreduc
condit
electrophoret
mobil
hef
suggest
molecular
weight
accord
size
deduc
sequenc
data
presenc
reduc
agent
electrophoret
migrat
uncleav
glycoprotein
suggest
molecular
weight
size
rang
expect
glycosyl
hef
shift
look
form
form
also
observ
nonreduc
condit
proteolyt
cleavag
hef
disulfidebond
product
hef
hef
design
hef
evid
releas
polypeptid
could
obtain
would
explain
shift
molecular
weight
meierewert
et
al
therefor
assum
uncleav
glycoprotein
peculiar
conform
maintain
disulfid
bond
conform
may
allow
associ
reduc
amount
sd
therebi
caus
aberr
electrophoret
migrat
behavior
conform
constraint
releas
either
abolish
disulfid
bond
proteolyt
cleavag
hef
hef
hef
known
whether
format
disulfid
bond
coor
posttransl
modif
glycoprotein
proteolyt
cleavag
found
late
modif
pulsechas
experi
hardli
cleav
glycoprotein
detect
infect
chick
kidney
cell
therefor
proteolyt
cleavag
may
occur
shortli
viru
particl
releas
bud
modif
influenza
c
glycoprotein
describ
recent
acyl
fatti
acid
veit
et
al
acyl
chain
attach
presum
cystein
residu
indic
releas
treatment
either
hydroxylamin
mercaptoethanol
labil
thioestertyp
linkag
found
mani
acyl
glycoprotein
viral
cellular
origin
case
test
palmit
acid
predomin
fatti
acid
hef
glycoprotein
uniqu
respect
stearic
acid
detect
prevail
fatti
acid
reason
differ
acyl
unknown
cystein
residu
cytoplasm
tail
identifi
fatti
acid
attach
site
sever
glycoprotein
cytoplasm
domain
hef
short
contain
singl
cystein
therefor
candid
attach
stearic
acid
far
biolog
function
attribut
fatti
acid
influenza
c
glycoprotein
characterist
featur
influenza
c
viru
reveal
electron
microscopi
long
protein
analyz
surfac
project
usual
arrang
reticular
structur
consist
mainli
hexagon
flewett
apostolov
seen
filament
spheric
particl
fig
singl
spike
protein
observ
six
vertic
hexagon
herrler
et
al
valu
length
individu
spike
rang
nm
lowresolut
structur
spike
determin
electron
microscopi
indic
influenza
c
glycoprotein
trimer
hewat
et
al
trimer
structur
confirm
sediment
glycoprotein
sucros
gradient
analyz
formanowski
meierewert
formanowski
et
glycoprotein
releas
viral
surfac
bromelain
treatment
still
found
trimer
indic
membran
anchor
cytoplasm
tail
essenti
maintain
structur
calcium
ion
howev
appear
play
import
role
sucros
gradient
centrifug
bromelainreleas
hef
trimer
detect
presenc
calcium
ion
calciumdefici
buffer
use
glycoprotein
dissoci
monom
formanowski
meierewert
formanowski
et
al
later
interact
trimer
spike
glycoprotein
probabl
involv
format
hexagon
array
viral
surfac
suggest
find
reticular
arrang
sometim
maintain
remov
spike
viral
membran
either
proteas
treatment
spontan
releas
herrler
et
al
later
interact
also
suggest
electron
micrograph
detergentisol
spike
remov
deterg
membran
glycoprotein
eg
influenza
hemagglutinin
form
rosett
protein
connect
central
point
via
hydrophob
membran
anchor
contrast
influenza
c
glycoprotein
arrang
elong
beetlelik
structur
individu
spike
stand
side
side
formanowski
et
al
formanowski
et
al
later
interact
depend
proteolyt
cleavag
glycoprotein
hexagon
array
observ
viru
contain
predominantli
hef
well
viru
contain
hef
glycoprotein
uncleav
form
also
maintain
reticular
pattern
ph
cleav
glycoprotein
howev
undergo
major
conform
chang
low
ph
result
loss
regular
hexagon
arrang
spike
hewat
et
al
formanowski
et
al
report
crystal
bromelainreleas
hef
obtain
suitabl
xray
diffract
studi
rosenth
et
al
thu
hope
near
futur
threedimension
structur
influenza
c
glycoprotein
known
would
repres
major
progress
toward
understand
structurefunct
relationship
among
monoclon
antibodi
direct
protein
two
group
distinguish
group
antibodi
inhibit
hemagglutin
hemolyt
activ
neutral
infect
influenza
c
viru
wherea
group
b
antibodi
lack
reactiv
analysi
antigen
variant
select
resist
either
monoclon
antibodi
suggest
presenc
four
antigen
epitop
competit
bind
assay
indic
site
may
locat
close
one
anoth
epitop
shown
sensit
denatur
condit
eg
treatment
sd
therefor
western
blot
hef
detect
group
b
antibodi
result
indic
site
sequencedepend
epitop
wherea
site
conformationdepend
epitop
conform
epitop
found
depend
glycosyl
hef
nonglycosyl
form
protein
synthes
presenc
tunicamycin
recogn
group
b
antibodi
group
antibodi
react
poorli
hongo
et
al
sugawara
et
al
antigen
site
presum
differ
function
epitop
receptorbind
receptordestroy
activ
abil
sever
monoclon
antibodi
inhibit
hemagglutin
activ
influenza
c
viru
vlasak
et
al
herrler
et
al
may
due
steric
hindranc
antibodi
caus
partial
inhibit
receptordestroy
enzym
esteras
activ
determin
larg
substrat
inhibitori
effect
observ
small
substrat
use
vlasak
et
al
herrler
et
al
hachinoh
et
al
antigen
variat
among
differ
strain
influenza
c
viru
less
pronounc
case
influenza
virus
sever
report
reveal
high
degre
crossreact
differ
strain
irrespect
time
place
isol
czekalowski
prasad
chakraverti
chakraverti
meierewert
et
al
kawamura
et
al
use
monoclon
antibodi
possibl
howev
demonstr
antigen
variat
adachi
et
al
low
extent
variat
due
low
capac
produc
antigen
variant
escap
mutant
resist
monoclon
antibodi
obtain
frequenc
similar
valu
report
influenza
viru
mayb
immun
select
less
pronounc
case
influenza
c
viru
may
also
explain
antigen
drift
observ
group
virus
among
antigen
variant
aris
within
influenza
virus
one
usual
becom
domin
replac
older
one
contrast
analys
differ
influenza
c
strain
indic
sever
antigen
variant
cocircul
adachi
et
al
conclus
support
studi
genet
variat
hef
well
ns
gene
influenza
c
viru
buonagurio
et
al
buonagurio
et
al
kawamura
et
al
adachi
et
al
although
receptordestroy
enzym
influenza
c
viru
describ
hirst
year
pass
specif
elucid
identif
enzym
activ
accomplish
analyz
effect
hemagglutin
inhibitor
rat
serum
long
known
inhibitori
activ
styk
ocallaghan
et
al
two
compon
rat
serum
shown
account
hemagglutin
inhibit
activ
murinoglobulin
macroglobulin
herrler
et
al
carbohydr
portion
latter
compound
found
consist
primarili
nlink
biantennari
oligosaccharid
herrler
et
al
effect
influenza
c
enzym
oligosaccharid
chang
termin
sialic
acid
residu
nativ
macroglobulin
contain
sialic
acid
acid
amount
reduc
treatment
receptordestroy
enzym
concomit
decreas
sialic
acid
increas
nacetylneuramin
acid
observ
herrler
et
al
effect
obtain
bovin
submandibulari
mucin
anoth
hemagglutin
inhibitor
case
chang
sialic
acid
parallel
loss
inhibitori
activ
indic
receptordestroy
enzym
influenza
c
viru
sialat
fig
enzym
shown
function
hef
sever
approach
express
clone
hef
gene
vertebr
cell
vlasak
et
al
analysi
purifi
protein
isol
deterg
herrler
et
al
proteas
treatment
formanowski
meierewert
influenza
c
esteras
belong
class
serin
hydrolas
inhibit
diisopropyl
fluorophosph
dfp
inhibitor
abolish
enzym
activ
without
affect
hemagglutin
activ
muchmor
varki
find
suggest
activ
site
esteras
receptorbind
site
differ
epitop
influenza
c
glycoprotein
inform
amino
acid
crucial
format
activ
site
esteras
knowledg
serin
hydrolas
eg
trypsin
chymotrypsin
expect
enzym
mechan
involv
charg
relay
system
accomplish
catalyt
triad
compos
amino
acid
serin
histidin
aspart
acid
kraut
take
advantag
fact
dfp
bind
coval
serin
activ
site
serin
hydrolas
amino
acid
hef
identifi
activesit
serin
herrler
et
al
vlasak
et
al
amino
acid
part
sequenc
pheglyaspserarg
fig
motif
glyaspser
found
activ
site
mani
serin
hydrolas
includ
trypsin
chymotrypsin
follow
arginin
residu
detect
far
activ
site
acetylesteras
influenza
c
viru
coronavirus
see
section
iv
fig
inhibit
studi
argininespecif
modifi
reagent
suggest
arginin
residu
may
import
substrat
recognit
possibl
interact
carboxyl
group
acid
hay
varki
analysi
seri
compound
reveal
esteras
influenza
c
viru
high
specif
group
hydrolyz
highest
rate
among
natur
substrat
test
schauer
et
al
see
tabl
aromat
acet
eg
acet
anaphthyl
acet
cleav
higher
rate
vlasak
et
al
schauer
et
al
wagaman
et
al
compound
substrat
mani
serin
hydrolas
includ
proteas
therefor
suit
determin
enzym
specif
enabl
howev
fast
sensit
assay
anaphthyl
acet
shown
use
cytochem
detect
influenza
cinfect
cell
wagaman
et
al
treatment
erythrocyt
influenza
c
viru
report
chang
reactiv
cell
lectin
specif
nacetylgalactosamin
luther
et
al
find
infer
receptordestroy
enzym
abl
releas
acetyl
residu
nacetylgalactosamin
howev
direct
chemic
evid
support
conclus
apart
dfp
esteras
activ
influenza
c
viru
also
inhibit
phosphat
isocoumarin
schauer
et
al
vlasak
et
al
inhibit
esteras
dfp
isocoumarin
report
reduc
infect
viru
muchmor
varki
vlasak
et
al
find
may
suggest
receptordestroy
enzym
requir
viru
entri
cell
howev
hemagglutin
ie
receptorbind
hemolyt
ie
fusion
activ
affect
inactiv
esteras
muchmor
varki
vlasak
et
al
thu
experi
necessari
show
whether
reduct
infect
correl
inhibit
enzym
activ
whether
due
n
indirect
effect
inhibitor
identif
receptordestroy
enzym
sialat
impli
see
fig
crucial
compon
cellular
receptor
influenza
c
viru
herrler
et
al
direct
evid
role
receptor
determin
provid
studi
erythrocyt
modifi
contain
singl
type
sialic
acid
influenza
c
viru
abl
agglutin
erythrocyt
sialyl
cell
contain
nacetylor
nglycolylneuramin
acid
roger
et
al
see
tabl
basi
result
possibl
explain
previou
observ
seem
argu
involv
sialic
acid
attach
influenza
c
viru
cell
resist
erythrocyt
receptor
period
treatment
ohuchi
et
al
due
greatli
reduc
oxid
period
compar
haverkamp
et
al
difficulti
inactiv
influenza
c
receptor
viral
bacteri
neuraminidas
hirst
kendal
herrler
et
al
explain
rel
resist
action
enzym
corfield
et
al
import
receptor
determin
restrict
erythrocyt
sialic
acid
also
requir
influenza
c
viru
initi
infect
cultur
cell
herrler
klenk
fact
lack
type
sialic
acid
major
reason
resist
mani
cell
line
influenza
c
viru
insert
artifici
receptor
plasma
membran
cultur
cell
render
sever
resist
cell
sensit
influenza
c
infect
moreov
increas
yield
viru
observ
cell
usual
produc
low
amount
viru
herrler
klenk
presenc
sialic
acid
appear
major
factor
determin
whether
glycoconjug
serv
receptor
influenza
c
viru
erythrocyt
resialyl
contain
agglutin
influenza
c
viru
regardless
whether
sialic
acid
molecul
attach
galactos
via
linkag
roger
et
al
see
tabl
sialyltransferas
specif
latter
linkag
type
act
glycoprotein
therefor
receptor
gener
enzym
glycoprotein
hand
shown
bovin
brain
gangliosid
also
serv
receptor
influenza
c
viru
although
activ
speci
among
mixtur
gangliosid
determin
herrler
klenk
b
thu
glycoprotein
glycolipid
use
receptor
influenza
c
viru
provid
contain
larger
number
glycoconjug
must
analyz
howev
order
know
whether
factor
presenc
import
receptor
function
glycoconjug
suggest
addit
influenza
c
viru
may
also
recogn
nacetylgalactosamin
luther
et
al
conclus
base
find
mention
section
erythrocyt
treat
influenza
c
viru
differ
control
cell
reactiv
lectin
specif
nacetylgalactosamin
howev
direct
evid
receptor
specif
lack
amino
acid
involv
receptorbind
site
hef
determin
valuabl
inform
obtain
analysi
mutant
chang
receptorbind
activ
mutant
describ
expand
cell
tropism
due
effici
recognit
receptor
compar
parent
viru
szepanski
et
al
sequenc
analysi
mutant
indic
singl
point
mutat
thr
isoleucin
see
fig
respons
chang
receptorbind
activ
szepanski
et
al
interestingli
mutat
site
locat
next
sequenc
glyasnsergli
similar
form
glyglnsergli
also
found
sever
subtyp
influenza
hemagglutinin
fig
homolog
sequenc
subtyp
compos
amino
acid
shown
part
receptorbind
pocket
wei
et
al
data
suggest
amino
acid
gli
thr
may
constitu
receptorbind
site
hef
mutant
alter
site
observ
amino
acid
locat
unfold
polypeptid
distanc
far
ser
catalyt
center
esteras
togeth
dfp
effect
section
iii
support
notion
receptor
bind
receptor
inactiv
exert
differ
structur
domain
hef
anoth
exampl
influenza
c
viru
chang
receptorbind
activ
report
camilleri
maassab
viru
isol
persist
infect
mdck
cell
found
sensit
action
hemagglutin
inhibitor
wildtyp
viru
sequenc
analysi
mutant
variant
type
help
defin
receptordestroy
receptorbind
site
hef
obvious
howev
final
answer
problem
given
threedimension
structur
glycoprotein
avail
import
individu
amino
acid
involv
format
function
epitop
evalu
sitedirect
mutagenesi
abil
influenza
c
glycoprotein
attach
receptor
use
power
tool
detect
sialic
acid
muchmor
varki
abil
influenza
c
viru
agglutin
erythrocyt
adult
chicken
ldayold
chicken
basi
discoveri
differenti
marker
chicken
erythrocyt
confirm
chemic
analysi
sialic
acid
cell
sensit
receptor
recognit
influenza
c
viru
evid
studi
human
erythrocyt
chemic
analysi
detect
shukla
schauer
agglutin
bind
studi
indic
howev
erythrocyt
individu
contain
low
level
sialic
acid
surfac
ohuchi
et
al
nishimura
et
al
fusion
activ
influenza
c
viru
first
demonstr
erythrocyt
microscop
observ
virusinduc
cell
fusion
photometr
detect
hemolysi
indic
viru
abl
fuse
mous
chicken
erythrocyt
ohuchi
et
al
kitam
et
al
recent
fusion
viru
membran
artifici
membran
monitor
use
reson
energi
assay
formanowski
et
al
contrast
hemagglutin
herrler
et
al
sugawara
et
al
esteras
activ
hef
herrler
et
al
fusion
activ
requir
proteolyt
cleavag
hef
polypeptid
hef
hef
ohuchi
et
al
kitam
et
al
describ
section
b
depend
influenza
c
virusinduc
fusion
cleavag
hef
indic
activ
function
surfac
glycoprotein
viru
uncleav
glycoprotein
render
fusiogen
uitro
cleavag
hef
trypsin
elastas
shown
effect
respect
wherea
proteas
eg
chymotrypsin
thermolysin
unabl
activ
glycoprotein
kitam
et
al
ohuchi
et
al
formanowski
et
al
addit
characterist
fusion
activ
ph
depend
similar
influenza
b
virus
sever
virus
influenza
c
viru
caus
fusion
low
ph
optim
ph
valu
hemolysi
erythrocyt
vari
depend
viru
strain
optim
fusion
viru
unilamellar
liposom
detect
rang
sever
chang
observ
glycoprotein
shift
neutral
acid
ph
valu
glycoprotein
becom
suscept
trypsin
digest
endogen
tryptophan
fluoresc
decreas
hexagon
arrang
surfac
project
disappear
formanowski
et
al
chang
observ
viru
contain
cleav
hef
ie
hef
suggest
exposur
low
ph
result
conform
chang
glycoprotein
characterist
influenza
c
virusinduc
fusion
describ
far
ie
depend
proteolyt
cleavag
low
ph
conform
chang
low
ph
similar
report
fusion
activ
influenza
b
virus
therefor
like
fusion
occur
similar
mechan
influenza
virus
influenza
viru
wide
accept
conform
chang
observ
acid
ph
result
exposur
aminotermin
portion
membranebound
cleavag
product
ha
part
protein
made
stretch
hydrophob
amino
acid
probabl
interact
cellular
membran
therebi
induc
fusion
viral
envelop
membran
target
cell
model
also
applic
influenza
c
viru
differ
influenza
c
virus
observ
far
kinet
fusion
process
concern
case
influenza
viru
conform
chang
fast
later
step
rate
limit
influenza
c
viru
conform
chang
found
ratelimit
step
formanowski
et
al
reason
delay
conform
chang
may
relat
hexagon
arrang
spike
close
pack
glycoprotein
might
hindranc
adopt
conform
requir
fusion
cours
viru
infect
viral
fusion
activ
crucial
penetr
envelop
virus
virus
phdepend
fusion
activ
gener
assum
enter
cell
via
endosom
acid
ph
within
vesicl
trigger
fusion
reaction
result
releas
nucleocapsid
cytoplasm
may
also
appli
influenza
c
viru
although
evid
present
support
assumpt
case
fusion
activ
crucial
infect
viru
viru
uncleav
glycoprotein
lack
fusion
activ
also
infect
herrler
et
al
sugawara
et
al
restor
fusion
activ
vitro
proteolyt
cleavag
glycoprotein
accompani
restor
infect
due
characterist
glycoprotein
hef
influenza
c
viru
uniqu
among
myxovirus
influenza
b
virus
well
paramyxovirus
differ
influenza
c
viru
specif
receptorbind
activ
versu
gacj
receptordestroy
enzym
neuraminidas
versu
acetylesteras
addit
hef
respons
three
activ
receptor
bind
receptor
inactiv
fusion
paramyxovirus
influenza
b
virus
two
surfac
glycoprotein
activ
fig
uniqu
characterist
influenza
c
glycoprotein
reflect
design
hef
propos
indic
protein
function
hemagglutinin
esteras
fusion
factor
herrler
et
al
other
chosen
design
vlasak
et
al
ignor
fusion
activ
addit
protein
present
coronavirus
cavanagh
et
al
protein
describ
section
iv
hemagglutin
esteras
activ
fusion
activ
thu
h
e
f
appropri
design
influenza
c
glycoprotein
distinguish
coronaviru
glycoprotein
mani
year
orthoand
paramyxovirus
thought
anim
virus
contain
receptordestroy
enzym
prompt
sequenc
similar
open
read
frame
genom
mous
hepat
viru
hef
gene
influenza
c
viru
luytj
etal
found
bovin
coronaviru
bcv
abl
inactiv
receptor
erythrocyt
vlasak
et
al
enzym
turn
sialat
similar
receptordestroy
enzym
influenza
c
viru
fact
coronaviru
enzym
abl
inactiv
receptor
influenza
c
viru
erythrocyt
esteras
influenza
c
viru
inactiv
receptor
bcv
vlasak
etal
indic
virus
use
receptor
determin
attach
cell
ie
conclus
confirm
resialyl
studi
erythrocyt
extend
porcin
coronaviru
hemagglutin
encephalomyel
viru
hev
schultz
et
al
acetylesteras
activ
report
bcv
also
hev
strain
mous
hepat
viru
yokomori
et
al
schultz
et
al
pfleider
et
al
acetylesteras
activ
bcv
shown
function
surfac
glycoprotein
detect
disulfidelink
dimer
molecular
weight
vlasak
et
schultz
et
protein
identifi
previous
hemagglutinin
king
et
al
therefor
design
chosen
indic
dual
function
hemagglutinin
esteras
cavanagh
et
al
similar
influenza
c
counterpart
esteras
coronavirus
serin
esteras
inhibit
dfp
vlasak
et
al
schultz
et
al
schultz
et
al
inhibit
enzym
activ
result
dramat
reduct
infect
suggest
import
role
esteras
earli
stage
infect
vlasak
et
al
import
protein
also
demonstr
monoclon
antibodi
align
amino
acid
sequenc
hef
protein
influenza
protein
mous
hepat
viru
strain
jhm
everi
tenth
posit
indic
dot
wavi
line
indic
hydrophob
sequenc
hef
compos
aminotermin
signal
sequenc
amino
acid
presumpt
fusion
peptid
amino
acid
membran
anchor
amino
acid
two
hydrophob
region
signal
peptid
amino
acid
membran
anchor
amino
acid
align
correspond
domain
hef
activesit
serin
acetylesteras
conserv
protein
mark
open
triangl
stretch
amino
acid
ident
sequenc
indic
underscor
vertic
line
indic
ident
relat
amino
acid
figur
base
align
hefl
courtesi
g
siddel
shown
neutral
bcv
uiuo
uitro
deregt
et
al
amino
acid
sequenc
protein
align
sequenc
influenza
c
glycoprotein
hef
homolog
observ
hef
cleavag
product
sequenc
protein
relat
hef
polypeptid
fig
observ
surpris
hef
respons
fusion
activ
influenza
c
viru
wherea
case
coronavirus
fusion
function
protein
review
homolog
amino
acid
sequenc
hef
report
align
indic
mani
conserv
substitut
region
complet
ident
sequenc
fig
among
sequenc
pheglyaspserarg
case
influenza
c
viru
shown
contain
activesit
serin
esteras
herrler
et
al
vlasak
et
al
interest
note
hand
put
constitu
sequenc
hef
receptorbind
site
gli
homolog
counterpart
sequenc
observ
may
relat
recent
find
effici
agglutin
erythrocyt
schultz
et
al
major
hemagglutinin
bcv
peplom
glycoprotein
schultz
et
al
argu
extent
ident
hef
high
enough
rule
converg
evolut
therefor
specul
coronavirus
acquir
gene
influenza
c
viru
nonhomolog
recombin
ancestor
virus
howev
acetylesteras
also
found
cell
coronavirus
actual
acquir
esteras
gene
recombin
event
gene
might
well
deriv
cellular
gene
inform
viral
cellular
esteras
requir
distinguish
possibl
